发明名称 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders
摘要 The present invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. In addition, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a single dose of a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. Further, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor in an isolated cell, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound.
申请公布号 US2011319451(A1) 申请公布日期 2011.12.29
申请号 US200913055128 申请日期 2009.07.22
申请人 LEONARD JAMES N.;CHU ZHI-LIANG;SMITH BRIAN M. 发明人 LEONARD JAMES N.;CHU ZHI-LIANG;SMITH BRIAN M.
分类号 A61K31/4439;A61P3/04;A61P3/06;A61P3/08;A61P3/10;A61P5/48;C12Q1/02 主分类号 A61K31/4439
代理机构 代理人
主权项
地址